Kjer-Nielsen L, Perera J D, Boyd L F, Margulies D H, McCluskey J
Department of Pathology and Immunology, Monash Medical School, Melbourne, Australia.
J Immunol. 1990 Apr 15;144(8):2915-24.
We have evaluated the relative contributions of the extracellular and cytoplasmic domains of MHC class II molecules in determining the Ag-processing requirements for class II-restricted Ag presentation to T cells. Hybrid genes were constructed to encode a heterodimeric I-Ak molecule in which the extracellular portion of the molecule resembled wild type I-Ak but where the connecting stalk, transmembrane and cytoplasmic domains of both the alpha- and beta-chain were derived from the class I molecule H-2Dd. Mutant I-Ak molecules were expressed as heterodimeric membrane glycoproteins reactive with mAb specific for wild type I-Ak. Fibroblast and B lymphoma cells expressing either wild type or mutant I-Ak molecules were able to process and present hen egg lysozyme (HEL) and conalbumin to Ag-specific, I-Ak-restricted, T cell hybridomas or clones. The mutant-expressing cells presented native and peptide Ag less efficiently than the wild type-expressing cells, suggesting that the disparity in presentation efficiency was not due to a difference in Ag processing. CD4 interaction was intact on the mutant I-Ak molecules. Presentation of native Ag by mutant and wild type-I-Ak-expressing cells was abolished by preincubation with chloroquine, or after paraformaldehyde fixation. After transfection of a cDNA encoding the gene for HEL, neither mutant nor wild type-I-Ak-expressing cells presented endogenously synthesized HEL to a specific T hybrid. Newly synthesized mutant I-Ak molecules were associated with invariant chain. These data demonstrate the ability of hybrid class II molecules to associate intracellularly with invariant chain and degraded foreign Ag in a conventional class II-restricted processing pathway indicating that the extracellular domains of class II molecules play a dominant role in controlling these Ag-processing requirements.
我们评估了MHC II类分子的细胞外和细胞质结构域在确定II类限制性抗原呈递给T细胞的抗原加工要求方面的相对贡献。构建了杂合基因以编码异二聚体I-Ak分子,其中该分子的细胞外部分类似于野生型I-Ak,但α链和β链的连接柄、跨膜和细胞质结构域均来自I类分子H-2Dd。突变的I-Ak分子表达为与野生型I-Ak特异性单克隆抗体反应的异二聚体膜糖蛋白。表达野生型或突变型I-Ak分子的成纤维细胞和B淋巴瘤细胞能够加工并将鸡卵溶菌酶(HEL)和伴清蛋白呈递给抗原特异性、I-Ak限制性的T细胞杂交瘤或克隆。表达突变体的细胞呈递天然和肽抗原的效率低于表达野生型的细胞,这表明呈递效率的差异不是由于抗原加工的差异所致。突变的I-Ak分子上的CD4相互作用是完整的。用氯喹预孵育或在多聚甲醛固定后,表达突变体和野生型I-Ak的细胞对天然抗原的呈递被消除。转染编码HEL基因的cDNA后,表达突变体或野生型I-Ak的细胞均未将内源性合成的HEL呈递给特异性T杂交瘤。新合成的突变I-Ak分子与恒定链相关。这些数据证明了杂合II类分子在细胞内与恒定链结合并在传统的II类限制性加工途径中降解外来抗原的能力,表明II类分子的细胞外结构域在控制这些抗原加工要求中起主导作用。